Vaccinology
In plain English
AI plain-English summaryAfrica still lacks effective vaccines for HIV, major outbreak viruses, and parasitic worm infections like schistosomiasis—and even existing vaccines work less well in poor, rural, tropical communities than elsewhere. This research theme tackles that gap head-on. It does not study vaccines in isolation; it asks why vaccines fail or succeed differently across communities, and what can be done about it. The team will develop and test new vaccines in African clinical trials—for example, a vaccine against Rift Valley Fever, a virus that causes recurring outbreaks in humans and livestock across East Africa. They will also investigate how to combine vaccines with other HIV prevention tools, determine optimal dosing schedules for different age groups, and study how communities learn about, perceive, and build confidence in vaccines. If successful, the work could lead to new vaccines for diseases that currently have none, and to practical strategies—dosing schedules, delivery methods, community engagement approaches—that make existing vaccines work more equitably. The project also builds vaccine research expertise among African scientists, strengthening the continent’s capacity to respond to its own infectious disease priorities.
View original technical description
View the original record at the funder ↗
Related Research
Grants with similar aims, by meaning.
Original classification
IntramuralPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know